This is an archive of news stories and research from the National Union of Public and General Employees. Please see our new site - https://nupge.ca - for the most current information.
Research finds that the EU proposal would likely add an average life of 2.66 years to a typical drug patent increasing Canadian drug costs by between $795 million and $1.95 billion annually.